Valley is aware of the nationwide supply disruption of IV fluid solution due to Hurricane Helene, and wants to reassure the community that steps have been taken to ensure the situation will have no negative impact on our patients and the community.
Cardiac amyloidosis, also known as stiff heart syndrome, occurs when abnormal proteins, called amyloid fibrils, accumulate in the heart and surrounding tissues. This causes the heart muscle to become stiff and thicken. This condition can affect the proper function of the heart and can lead to heart failure symptoms. It is one of the most common types of restrictive cardiomyopathy.
The two most common types of cardiac amyloidosis are amyloid light-chain (AL) amyloidosis and transthyretin (ATTR) amyloidosis. AL amyloidosis is a result of light chain proteins that are produced by plasma cells in bone marrow. ATTR amyloidosis is caused by a protein produced in the liver.
Cardiac amyloidosis can be diagnosed in a variety of ways including:
At Valley, our Center for Heart Failure Care team is trained in the diagnosis and treatment of cardiac amyloidosis. Treatment options may vary depending on the type of cardiac amyloidosis you have.
Treatment options may include: